Aethlon Medical 2023 LD Micro Invitational Conference

Aethlon Medical presented its immunotherapeutic platform focused on cancer and infectious disease treatment at the LD Micro Invitational XIII Conference. The company highlighted its first-in-class Hemopurifier device, which has demonstrated exosome and circulating virus capture in clinical trials and received FDA Breakthrough Device designation for two indications. Aethlon maintains a solid financial position with no debt and is advancing clinical development of its lead therapeutic technology.